Search
-
Para las personas con leucemia linfocítica aguda (LLA), nuestros médicos pueden recomendar quimioterapia, terapia dirigida, inmunoterapia como la terapia de células T con CAR o trasplante de médula ósea. Lea más sobre sus opciones.
… New Patient Appointments Call 646-497-9154 We’re available 24 hours a day, 7 days a week Make an Appointment Los tratamientos convencionales para la leucemia linfocítica aguda (LLA) que comienza en la edad adulta son la quimioterapia y el trasplante de células madre (médula ósea) . Según las características
-
Pituitary Gland Tumors & Adenomas
Pituitary tumors are abnormal growths of cells in the pituitary gland. Learn about types, symptoms, and treatment options at Memorial Sloan Kettering.
… A pituitary tumor, also called a pituitary gland tumor, is an abnormal growth of cells that occurs in the pituitary gland. Most of these tumors are benign (not cancer), and do not spread to other parts of the body. The American Cancer Society estimates that around 10,000 people are diagnosed with a pituitary
-
Thyroid Cancer
Learn about active thyroid cancer clinical trials happening now at Memorial Sloan Kettering, where you may have access to treatments before they’re available elsewhere. Learn more.
… Memorial Sloan Kettering is known for its innovative research into all stages of thyroid cancer. We combine our understanding of the biology of thyroid cancer into findings that guide how best to diagnose and treat people with the disease in the most precise and effective way. One of the many benefits
-
Learn about how MSK treats pediatric liver cancer and tumors, why you should bring your child to MSK Kids for treatment.
… MSK Kids’ doctors customize your child’s treatment to the type and stage of their liver cancer and tumor and the risk of it coming back later. Most liver cancer patients have surgery, and some also have chemotherapy before and/or after surgery. Your team will explain every aspect of your child’s care
-
Plasmacytoma (PLAZ-muh-sy-TOH-muh) is a type of cancer that starts in plasma cells. It can become multiple myeloma.
… Plasmacytoma (PLAZ-muh-sy-TOH-muh) is a very rare blood cancer. Fewer than 1,000 people each year are diagnosed with it in the United States. We do not know what causes plasmacytoma. Plasmacytoma is similar to multiple myeloma. It happens when plasma cells become abnormal, multiply, and make m-protein
-
Stomach cancer symptoms can be easy to miss. Learn more about the signs of stomach cancer, which can include upset stomach, indigestion, and bloating.
… What are the signs and symptoms of stomach cancer? Stomach cancer, also called gastric cancer, can have symptoms at an early stage. They can include an upset stomach and general stomach discomfort. But these also are common signs of other things, such as indigestion or a stomach virus (bug). That’s why
-
Appendiceal Cancer
Learn about active appendiceal (appendix) cancer clinical trials happening now at Memorial Sloan Kettering, where you may have access to treatments before they’re available elsewhere. Learn more.
… Researchers at Memorial Sloan Kettering are exploring new therapies and diagnostic tools for appendiceal cancer. If you qualify, your treatment team can recommend one of our clinical trials if they feel it may help improve your condition.
-
The esophagus.
-
Learn about Hemoglobinopathy disorders to help understand how patients with beta-thalassemia and sickle cell disease can receive supportive care, and in some cases, a cure through stem cell transplantation. Learn more at Memorial Sloan Kettering.
… Red blood cells carry hemoglobin, a vital protein that delivers oxygen throughout the body. Disorders that affect hemoglobin are known as hemoglobinopathies. They are the most common inherited blood disorders and affect millions of people around the world. People with a low number of red blood cells
-
Memorial Sloan Kettering was among the nation’s first institutions to see people with KS as a result of HIV/AIDS-related disease, and we continue to treat dozens annually.
… At Memorial Sloan Kettering, we are experienced in diagnosing and treating people with Kaposi sarcoma (KS), and were among the nation’s first institutions to treat people with the condition as a result of HIV/AIDS-related disease. Each year we treat dozens of people with KS. While the illness cannot